A "brutally honest" new exhibition explores the realities of living with depression. Nicola Davis, a Wiltshire-based textile ...

Health stickers claim to help cure everything from fatigue to period pains. Could we all soon be swapping pills for adhesive patches? Lydia Spencer-Elliott speaks to the experts and puts the product t ...

Packet loss has been a consistent issue in Battlefield 6 since its launch, with community members reporting lag, rubber-banding, frame hitches and stutters, and other network-related issues for months ...

Jan. 5 (UPI) --Pharmaceutical company Novo Nordisk announced Monday that a new pill-version of its GLP-1 weight-loss drug is now "broadly available" at U.S. pharmacies. The Wegovy pill, available in ...

Novo Nordisk’s NOVO.B1.17%increase; green up pointing triangle Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish ...

American patients can now receive the first-ever GLP-1 pill for weight loss from Novo Nordisk, marking a new chapter of obesity treatment in the U.S. The cash prices for the drug, called the Wegovy ...

For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is ...

The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. The full launch of the pill is expected in January.

The U.S. Food and Drug Administration-approved Wegovy pill will be here before you'd think. Fresh off winning approval from the FDA in December, Wegovy manufacturer Novo Nordisk says it will have the ...

LONDON, Dec 23 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying consumer market, with plans ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 ...